EC Healthcare
UNHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $4,140,212 | $4,211,034 | $3,875,377 | $2,919,500 |
| % Growth | -1.7% | 8.7% | 32.7% | – |
| Cost of Goods Sold | $797,951 | $666,132 | $552,953 | $349,603 |
| Gross Profit | $3,342,261 | $3,544,902 | $3,322,424 | $2,569,897 |
| % Margin | 80.7% | 84.2% | 85.7% | 88% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $254,900 | $219,151 | $232,647 | $162,640 |
| SG&A Expenses | $432,369 | $426,373 | $405,362 | $302,023 |
| Sales & Mktg Exp. | $177,469 | $207,222 | $172,715 | $139,383 |
| Other Operating Expenses | $2,814,952 | $2,932,499 | -$36,413 | -$40,671 |
| Operating Expenses | $3,247,321 | $3,358,872 | $3,078,986 | $2,177,657 |
| Operating Income | $94,940 | $109,041 | $218,942 | $363,065 |
| % Margin | 2.3% | 2.6% | 5.6% | 12.4% |
| Other Income/Exp. Net | -$196,080 | -$92,167 | -$55,372 | -$10,256 |
| Pre-Tax Income | -$101,140 | $16,874 | $136,189 | $321,411 |
| Tax Expense | $10,778 | $1,179 | $29,162 | $50,908 |
| Net Income | -$167,186 | -$18,947 | $69,654 | $197,501 |
| % Margin | -4% | -0.4% | 1.8% | 6.8% |
| EPS | -0.14 | -0.016 | 0.059 | 0.17 |
| % Growth | -775% | -127.1% | -65.3% | – |
| EPS Diluted | -0.14 | -0.016 | 0.059 | 0.17 |
| Weighted Avg Shares Out | 1,185,219 | 1,185,211 | 1,180,602 | 1,152,860 |
| Weighted Avg Shares Out Dil | 1,185,211 | 1,185,211 | 1,184,284 | 1,173,282 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17,400 | $15,573 | $4,526 | $1,364 |
| Interest Expense | $89,442 | $100,837 | $63,636 | $48,907 |
| Depreciation & Amortization | $630,977 | $625,545 | $586,735 | $432,365 |
| EBITDA | $619,279 | $743,256 | $786,560 | $802,683 |
| % Margin | 15% | 17.7% | 20.3% | 27.5% |